News & Press
ONWARD Medical Reports Full Year 2025 Financial and Operating Results
Euronext3/31/2026·03/31/26🌐 Europe
Summary
ONWARD Medical reported EUR 5.4 million in revenue, sold 117 ARC-EX Systems to over 80 US clinics, and received CE Mark certification for European commercialization. The company raised EUR 50.8 million in equity capital with Ottobock as a cornerstone investor. Four additional individuals received ARC-BCI Therapy, bringing total to seven participants.
Why it matters
ONWARD's strong commercial traction with 25% penetration of US specialized rehabilitation clinics demonstrates market demand for non-invasive spinal stimulation. The ARC-BCI system pairing brain-computer interfaces with implantable spinal stimulation represents cutting-edge neurotechnology.
#BCI#Spinal Cord Stimulation#Spinal Cord Injury#Europe#Industry#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in